Vial, a tech-enabled, next-generation CRO, announced on Sunday that it has added Dr Roberta Brinton as a new Central Nervous System (CNS) advisory board member.

Dr Brinton has served as the Director of the Center for Innovation in Brain Science and founded NeuTherapeutics. She will act as a founding scientific advisor to the company's Neurology CRO to support the needs of neurology sponsors and patients.

Dr Brinton, said, 'Vial is reimagining what the clinical trial space could look like through the lens of technology. In the neurology space, that is exactly the creative vision you need when developing new treatment methods.'